Indication for Skin-Sparing Mastectomy With or Without Nipple Preservation for Primary Breast Cancer

被引：0

作者：

Kontani, Keiichi ^{[1
]}

Murazawa, Chisa ^{[1
]}

Norimura, Shoko ^{[1
]}

Yamashita, Kanako ^{[1
]}

Fujiwara-Honjo, Naomi ^{[2
]}

Ohtani, Masahiro ^{[3
]}

Date, Manabu ^{[4
]}

Kushida, Yoshio ^{[5
]}

Muneuchi, Gan ^{[6
]}

Haba, Reiji ^{[5
]}

Yokomise, Hiroyasu ^{[1
]}

Yamauchi, Akira ^{[7
]}

机构：

[1] Kagawa Univ, Fac Med, Dept Resp Breast & Endocrine Surg, Takamatsu, Kagawa 7610793, Japan

[2] Osaka Neurosurg Hosp, Dept Radiol, Takamatsu, Kagawa, Japan

[3] Kagawa Hlth Serv Assoc, Hlth Care Ctr, Takamatsu, Kagawa, Japan

[4] Date Hosp, Dept Surg, Takamatsu, Kagawa, Japan

[5] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Kagawa 7610793, Japan

[6] Kagawa Univ, Fac Med, Dept Plast Surg, Kagawa 7610793, Japan

[7] Kagawa Univ, Fac Med, Dept Cell Regulat, Kagawa 7610793, Japan

来源：

INTERNATIONAL SURGERY | 2010年 / 95卷 / 01期

关键词：

Breast cancer; Skin-sparing mastectomy; Intraductal cancer growth; HER2; status; LOCAL RECURRENCE; INVOLVEMENT; AREOLA; RECONSTRUCTION; RISK;

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Skin-sparing mastectomy (SSM) is one of the available operation methods for breast cancer. We discuss here indications for SSM for primary breast cancer. We carried out SSM for 28 patients with breast cancer. Their clinical features were compared with those in patients who underwent breast-conserving treatment (BCT). Fifteen of the 28 patients received SSM according to schedule. The remaining 13 patients who were scheduled to undergo BCT received SSM because of involvement of the surgical margin. Clinical features indicating suitability for SSM included extensive intraductal cancer growth and multicentricity. The length of intraductal cancer growth in these patients was significantly greater than that in 24 patients who received BCT (2.28 versus 0.571 cm; P = 0.000078). Tumor size and tumor-nipple distance were not indicating factors for this treatment. SSM, which is advantageous in terms of aesthetic outcome and oncologic safety, may be widely indicated after careful evaluation by magnetic resonance imaging or pathologic examination.

引用

页码：12 / 20

页数：9

共 17 条

[1] Skin-sparing mastectomy - Specialty bias and worldwide lack of consensus [J].

Bleicher, RJ ;

Hansen, NM ;

Giuliano, AE .

CANCER, 2003, 98 (11) :2316-2321

[2] Skin-sparing mastectomy - Oncologic and reconstructive considerations [J].

Carlson, GW ;

Bostwick, J ;

Styblo, TM ;

Moore, B ;

Bried, JT ;

Murray, DR ;

Wood, WC .

ANNALS OF SURGERY, 1997, 225 (05) :570-575

[3] Skin-sparing mastectomy [J].

Cunnick, GH ;

Mokbel, K .

AMERICAN JOURNAL OF SURGERY, 2004, 188 (01) :78-84

[4] 5-YEAR RESULTS OF A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY AND SEGMENTAL MASTECTOMY WITH OR WITHOUT RADIATION IN THE TREATMENT OF BREAST-CANCER [J].

FISHER, B ;

BAUER, M ;

MARGOLESE, R ;

POISSON, R ;

PILCH, Y ;

REDMOND, C ;

FISHER, E ;

WOLMARK, N ;

DEUTSCH, M ;

MONTAGUE, E ;

SAFFER, E ;

WICKERHAM, L ;

LERNER, H ;

GLASS, A ;

SHIBATA, H ;

DECKERS, P ;

KETCHAM, A ;

OISHI, R ;

RUSSELL, I .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (11) :665-673

[5]

Jacobs TW, 1999, J CLIN ONCOL, V17, P3691

[6] Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer - A pooled analysis of updated results [J].

Jatoi, I ;

Proschan, MA .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (03) :289-294

[7] Local recurrence risk after skin-sparing and conventional mastectomy: A 6-year follow-up [J].

Kroll, SS ;

Khoo, A ;

Singletary, SE ;

Ames, FC ;

Wang, BG ;

Reece, GP ;

Miller, MJ ;

Evans, GRD ;

Robb, GL .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 104 (02) :421-425

[8] Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer [J].

Medina-Franco, H ;

Vasconez, LO ;

Fix, RJ ;

Heslin, MJ ;

Beenken, SW ;

Bland, KI ;

Urist, MM .

ANNALS OF SURGERY, 2002, 235 (06) :814-818

[9] Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy [J].

Mirza N.Q. ;

Vlastos G. ;

Meric F. ;

Buchholz T.A. ;

Esnaola N. ;

Eva Singletary S. ;

Kuerer H.M. ;

Newman L.A. ;

Ames F.C. ;

Ross M.I. ;

Feig B.W. ;

Pollock R.E. ;

McNeese M. ;

Strom E. ;

Hunt K.K. .

Annals of Surgical Oncology, 2002, 9 (3) :256-265

[10]

MORIMOTO T, 1985, CANCER-AM CANCER SOC, V55, P2459, DOI 10.1002/1097-0142(19850515)55:10<2459::AID-CNCR2820551025>3.0.CO

← 1 2 →